This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Progress in Poison Management

Daniel A. Spyker, MD, PhD

Arch Intern Med. 1985;145(1):43-44.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the January ARCHIVES, Curtis et al¹, described their study of the efficacy of ipecac alone v activated charcoal plus a cathartic v the three together in the treatment of a simulated aspirin tablet overdose. They accounted for 70% of the ingested aspirin dose in the urine of patients following a standard ipecac regimen, compared with 56% in patients receiving activated charcoal. Their results provided another piece of impressive evidence for the efficacy of activated charcoal in treating the overdose patient.

The fine, black, fluffy powder of activated charcoal used as an antidote since the 19th century results from the destructive distillation of organic materials, usually wood pulp. Following activation with steam or strong acid, activated charcoal's surface area (1,000 sq m/mL) and electrostatic properties favor binding with most poisons.

CLINICAL EXPERIENCE

Linden et al² reported on the use of repeated doses of activated charcoal in treating 11 . . . [Full Text PDF of this Article]

Author Affiliations
Box 484 Medical Center Department of Internal Medicine University of Virginia Medical School Charlottesville, VA 22908

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?